Equifax (EFX) Tops Q4 EPS by 4c, Offers Guidance
Get Alerts EFX Hot Sheet
Price: $177.05 --0%
Revenue Growth %: +9.7%
Financial Fact:
Consolidated net income: 134.9M
Today's EPS Names:
VIVO, BIOX, PMCB, More
Revenue Growth %: +9.7%
Financial Fact:
Consolidated net income: 134.9M
Today's EPS Names:
VIVO, BIOX, PMCB, More
Join SI Premium – FREE
Equifax (NYSE: EFX) reported Q4 EPS of $1.84, $0.04 better than the analyst estimate of $1.80. Revenue for the quarter came in at $1.25 billion versus the consensus estimate of $1.25 billion.
GUIDANCE:
Equifax sees Q1 2022 EPS of $2.08-$2.18, versus the consensus of $2.11. Equifax sees Q1 2022 revenue of $1.32-1.34 billion, versus the consensus of $1.29 billion.
Equifax sees FY2022 EPS of $8.50-$8.80, versus the consensus of $8.79. Equifax sees FY2022 revenue of $5.25-5.35 billion, versus the consensus of $5.34 billion.
For earnings history and earnings-related data on Equifax (EFX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- United Natural Foods (UNFI) Tops Q4 EPS by 8c ; Offers Guidance
- GE Aerospace to buy CPP for $11.75 billion in castings deal
- Citi turns more bullish on trucking stocks
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share